LivaNova (Nasdaq: LIVN)+
today announced 12-month data from its OSPREY study supporting an FDA submission of the aura6000 system.

BrightHeart earned its second FDA 510(k) clearance for updates to its BrightHeart platform, an AI-powered digital screening tool for congenital heart defects (CHDs).

Bausch + Lomb announced today that it received CE mark approval for its LuxLife full range of vision intraocular lens (IOL).

This historic acquisition reduces barriers that prevent people from taking control of their lifelong health. Full Body MRI scan now takes just 22 minutes instead of 60 minutes, costs $499 instead of over $1,500

MADISON, Wis., May 6, 2025 /PRNewswire/ — The Food and Drug Administration Agency (FDA) has updated the regulatory status of Marie®, Leo Cancer Care’s upright particle therapy solution, to pending. Marie combines Leo Cancer Care’s upright patient positioning system with their upright fan beam CT scanner and can be utilized with any fixed particle beam.

Yale researchers have built a 3D-bioprinted synthetic aorta that they have successfully implanted into rats. This technology could advance the treatment of cardiovascular diseases such as coronary artery disease or peripheral arterial disease by allowing scientists to engineer and replace blood vessels in humans.

AliveCor announced today that it launched its most advanced personal ECG system, the AI-powered KardiaMobile 6L Max.

People who are given a vaccine for shingles have a 23% lower risk of cardiovascular events, including stroke, heart failure, and coronary heart disease, according to a study of more than a million people published in the European Heart Journal.